Location Stockholm, Stockholms Lan, Sweden Regions European Union (EU), Nordic Countries, Scandinavia Gender Male
LinkedIn View on LinkedIn
Peder Walberg is the Board Member of TIRmed Pharma. He previously worked at Egetis Therapeutics AB as a Member of the Board of Directors. Peder Walberg attended Uppsala University.
Peder holds extensive experience from the development and commercialization of orphan drugs, both on an operational and board level. Peder’s background includes being
the founder and CEO of Medical Need Europe and EVP Business Development and Strategy at Sobi and Swedish Orphan. Peder has previously served as a director of the board of Wilson Therapeutics and OxThera and is currently on the board of Immedica.
